Option Care Health, Inc. $OPCH Shares Sold by Alliancebernstein L.P.

Key Points

• Alliancebernstein L.P. decreased its holdings in Option Care Health by 2.7%, now owning approximately 570,908 shares valued at $19.95 million.
• Recent transactions by insiders, including substantial purchases by directors, have increased their ownership stake, indicating potential confidence in the company.
• Brokerages have given Option Care Health a "Moderate Buy" rating with an average price target of $35.75, reflecting positive growth forecasts.

Alliancebernstein L.P. decreased its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 2.7% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 570,908 shares of the company's stock after selling 15,791 shares during the period. Alliancebernstein L.P. owned approximately 0.35% of Option Care Health worth $19,953,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of the business. Fuller & Thaler Asset Management Inc. raised its holdings in Option Care Health by 30.8% in the 1st quarter. Fuller & Thaler Asset Management Inc. now owns 4,204,481 shares of the company's stock valued at $146,947,000 after acquiring an additional 989,048 shares during the last quarter. Durable Capital Partners LP acquired a new stake in Option Care Health in the 1st quarter valued at about $122,905,000. Charles Schwab Investment Management Inc. raised its holdings in Option Care Health by 4.0% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 2,609,705 shares of the company's stock valued at $91,209,000 after acquiring an additional 99,574 shares during the last quarter. Nuveen LLC acquired a new stake in Option Care Health in the 1st quarter valued at about $70,965,000. Finally, The Manufacturers Life Insurance Company raised its holdings in Option Care Health by 8.8% in the 1st quarter. The Manufacturers Life Insurance Company now owns 1,651,489 shares of the company's stock valued at $57,720,000 after acquiring an additional 133,497 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company's stock.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on OPCH shares. Citigroup restated an "outperform" rating on shares of Option Care Health in a report on Thursday, July 31st. JMP Securities raised their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a "market outperform" rating in a report on Thursday, July 31st. Finally, Barrington Research restated an "outperform" rating and set a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. Eight research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $35.75.

Option Care Health Trading Down 3.0%

Option Care Health stock traded down $0.89 during trading on Friday, hitting $28.48. The company had a trading volume of 1,626,043 shares, compared to its average volume of 1,842,623. Option Care Health, Inc. has a 1-year low of $21.39 and a 1-year high of $35.53. The company has a current ratio of 1.52, a quick ratio of 1.00 and a debt-to-equity ratio of 0.81. The company's 50 day simple moving average is $29.09 and its 200-day simple moving average is $31.44. The stock has a market cap of $4.62 billion, a price-to-earnings ratio of 22.78, a price-to-earnings-growth ratio of 1.79 and a beta of 0.82.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating the consensus estimate of $0.40 by $0.01. Option Care Health had a net margin of 3.93% and a return on equity of 17.53%. The firm had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. During the same quarter last year, the firm earned $0.30 EPS. The firm's revenue for the quarter was up 15.4% on a year-over-year basis. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. As a group, analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Activity at Option Care Health

In related news, Director Timothy P. Sullivan bought 20,000 shares of the company's stock in a transaction that occurred on Thursday, August 21st. The stock was purchased at an average price of $27.51 per share, for a total transaction of $550,200.00. Following the acquisition, the director owned 49,229 shares of the company's stock, valued at approximately $1,354,289.79. This trade represents a 68.43% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Norman L. Wright purchased 3,411 shares of the company's stock in a transaction on Tuesday, September 9th. The stock was acquired at an average price of $29.31 per share, with a total value of $99,976.41. Following the purchase, the director owned 15,501 shares of the company's stock, valued at approximately $454,334.31. This represents a 28.21% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 59,411 shares of company stock worth $1,627,576. Insiders own 0.64% of the company's stock.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.